Back to PFE Stock Lookup

Pfizer (PFE) – Press Releases

Jan 22, 2015 11:21 AM Prevenar 13®* Receives CHMP Positive Opinion For Prevention Of Vaccine-Type Pneumococcal Pneumonia in Adults
Jan 8, 2015 08:30 AM Pfizer Provides Update on IBRANCE® (palbociclib)
Jan 7, 2015 08:00 AM Nodality Launches PathPro™ Product Line Based on Leading Single Cell Network Profiling (SCNPTM) Platform to Enhance Pharmaceutical R&D
Jan 6, 2015 10:00 AM Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference
Jan 5, 2015 07:30 AM Pfizer Acquires Redvax GmbH
Dec 18, 2014 08:00 AM Pfizer Reports Top-Line Results From a Phase 3 Study Evaluating Pregabalin Controlled-Release Formulation as a Treatment for Patients With Postherpetic Neuralgia
Dec 17, 2014 08:00 AM Pfizer Initiates Phase 2 Study of PF-06252616 in Duchenne Muscular Dystrophy
Dec 16, 2014 10:00 AM Pfizer Invites Public to View and Listen to Webcast of January 27 Conference Call with Analysts
Dec 16, 2014 08:00 AM Meningococcal Meningitis Survivor and TV Personality Amy Purdy and Pfizer Launch Take Action Against Meningitis
Dec 15, 2014 06:30 PM Pfizer Announces Palbociclib PALOMA-1 Data Published in The Lancet Oncology
Dec 15, 2014 12:06 PM Pfizer Declares First-Quarter 2015 Dividend
Dec 15, 2014 08:00 AM OPKO and Pfizer Enter into Global Agreement for OPKO’s Long-Acting Human Growth Hormone (hGH-CTP)
Dec 10, 2014 09:00 AM Pfizer and Brenda Strong Encourage Women to Change the Conversation on Sexual Health Post-Menopause
Dec 9, 2014 10:30 AM New Data at ASH 2014 Highlight Progress of Pfizer’s Growing Portfolio in Blood Cancers
Dec 8, 2014 01:30 PM Anticoagulant Effect of Eliquis (apixaban) Reversed by Two Separate 4-Factor Prothrombin Complex Concentrates in Healthy Subjects
Dec 8, 2014 08:00 AM Pfizer Expands Rare Disease Research with Establishment of Gene Therapy Platform
Dec 4, 2014 11:29 AM Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative
Dec 4, 2014 10:00 AM Mylan receives tentative FDA approval for pediatric formulations of abacavir/lamivudine through innovative collaboration with ViiV Healthcare and Clinton Health Access Initiative
Dec 3, 2014 05:07 PM Phase 3 Results Published in The New England Journal of Medicine Show Superiority of Pfizer’s XALKORI® (crizotinib) Compared to Platinum-Based Chemotherapy in Previously Untreated Patients With ALK
Dec 2, 2014 08:00 AM New Survey Finds Majority of Women with Breast Cancer Who Work Want to Do So Even While Undergoing Treatment
Dec 1, 2014 07:30 AM Pfizer Completes Acquisition of Baxter’s Marketed Vaccines
Nov 19, 2014 08:00 AM Nodality Develops Disease-Associated PD-1 Assay System for Application in Immuno-oncology
Nov 18, 2014 08:30 AM TRUMENBA® (Meningococcal Group B Vaccine) is Now Available
Nov 18, 2014 08:00 AM Nodality, Inc. Announces Data Presentation from Collaborative Program with UCB at American College of Rheumatology 2014 Annual Meeting
Nov 17, 2014 08:30 AM Nodality, Inc. Announces Data Presentations from Systemic Lupus Erythematosus Collaborative Programs at American College of Rheumatology 2014 Annual Meeting
Nov 17, 2014 08:00 AM Portola, Bristol-Myers Squibb and Pfizer Announce Statistically Significant Results From the First Part of the Phase 3 ANNEXA(TM)-A Studies of Investigational Andexanet Alfa With Eliquis (apixaban)
Nov 17, 2014 03:40 AM Merck KGaA, Darmstadt, Germany, Announces Global Strategic Alliance with Pfizer on Anti-PD-L1 to Accelerate Presence in Immuno-Oncology
Nov 17, 2014 02:53 AM Pfizer Forms Global Strategic Alliance with Merck KGaA, Germany, to Jointly Develop and Commercialize Anti-PD-L1 to Accelerate Presence in Immuno-Oncology
Nov 13, 2014 11:00 AM Novel Agreement Expands Access to Pfizer’s Contraceptive, Sayana® Press, for Women Most in Need in the World’s Poorest Countries
Nov 12, 2014 08:00 AM Pfizer Highlights Leadership in Rheumatology and Inflammation with Data to be Presented at the ACR/ARHP 2014 Annual Meeting
Nov 5, 2014 11:00 AM Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference
Oct 29, 2014 02:44 PM Pfizer Receives FDA Accelerated Approval for TRUMENBA® (Meningococcal Group B Vaccine) for the Prevention of Invasive Meningococcal B Disease in Adolescents and Young Adults
Oct 29, 2014 08:30 AM Pfizer’s PRISTIQ® (desvenlafaxine) Demonstrates Low Potential For Sexual Dysfunction in Adults with Major Depressive Disorder
Oct 28, 2014 07:00 AM PFIZER REPORTS THIRD-QUARTER 2014 RESULTS
Oct 27, 2014 08:05 AM DURECT Provides Update on REMOXY® and POSIDUR™ Programs
Oct 27, 2014 08:00 AM Pfizer to Discontinue Agreement on REMOXY™ (oxycodone) Extended-Release Capsules CII
May 19, 2014 08:05 AM Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index
Jan 13, 2014 08:00 AM Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With

Back to PFE Stock Lookup